This year BIT launched and shared their AR/VR 3D Immersive Experience with attendees of the 2018 AACC Annual Meeting & Expo. Industry leaders from all over the world had the chance to visit BIT’s booth and learn through hands-on experience how Augmented and Virtual Reality simulations will help create major opportunities for the future of medical device development, manufacturing, and services.

It is BIT’s pleasure to announce that Luis de Luzuriaga will be taking on with immediate effect the role as Global CEO for BIT Group. Luis has been with BIT for three months serving as the CEO for BIT USA. Prior to joining BIT USA, he was the GM and Divisional VP of Abbott Hematology and has previously worked for Leica Biosystems, a Danaher company, Siemens and Bayer.

BIT and Qorvo® Biotechnologies invite esteemed guests of this year’s AACC Annual Expo to enjoy cocktails and hors d’oeuvres, mingle with global executive management and learn about the processes that drove these two companies to innovate the Life Sciences industry together.

BIT will exhibit at the AACC Annual Meeting & Expo in Chicago, IL (USA) July 31- August 2, 2018 and invites attendees and exhibitors to meet with members of BIT’s global team at their newly designed multi-level booth #3248.

BIT will be attending the 2nd edition of MedFIT, the first European business convention that is dedicated to innovation partnerships and early-stage investment in medtech and diagnostics.

BIT will display two innovative instrument solutions at the ASM Microbe (taking place June 7-11 at the Georgia World Congress Center in Atlanta, Georgia).

BIT is your product development, manufacturing and service partner for high performance clinical, medical and life science devices. We BUILD INNOVATION TOGETHER with our partners.

BIT will display two innovative instrument solutions at the ECCMID 2018 congress taking place April 21-24 at the IFEMA Convention Center in Madrid, Spain.

My name is Mona Amin, working at BIT Group USA. One of my passions is to “Give Back” to my community and make a positive impact in peoples lives.

On 1st of September Mark Rahman joined BIT as Group Chief Financial Officer. Mark is an experienced global finance and strategy executive who has worked extensively across the world in both the production and service sectors in the healthcare, mining, chemical and retail industries.

In the Molecular Diagnostic (MDx) instrument development market, we are seeing many more opportunities for single point or small multiplex assays in small instruments. These Point of Care or Point of Collection (POC) opportunities are coming from two fronts.

Meet Global BIT Business Development Team at MedLab 2018 in Dubai. The 2018 MEDLAB held in Dubai, UAE, will start on February 5-8. With more than 600 exhibitors from 40 countries, more than 25,000 international attendees and 17 multi-disciplinary CME-accredited conferences, the show is known for being the largest multi-specialty laboratory expo worldwide.

BIT is glad to announce that Dr. Philippe Grandjean has joined as Vice President of Business Development Europe.

The AMP Annual Meeting is recognized as the premier gathering for molecular professionals as they seek to obtain critical, analytical patient care intelligence.

Dr. Josée Naegelen joins BIT as Vice President of Global Hematology Business Development Montpellier, France, Nov 6, 2017 – BIT…